Literature DB >> 25776759

Small particle aerosol inoculation of cowpox Brighton Red in rhesus monkeys results in a severe respiratory disease.

Reed F Johnson1, Dima A Hammoud2, Matthew G Lackemeyer3, Srikanth Yellayi3, Jeffrey Solomon2, Jordan K Bohannon3, Krisztina B Janosko3, Catherine Jett3, Kurt Cooper3, Joseph E Blaney4, Peter B Jahrling5.   

Abstract

Cowpox virus (CPXV) inoculation of nonhuman primates (NHPs) has been suggested as an alternate model for smallpox (Kramski et al., 2010, PLoS One, 5, e10412). Previously, we have demonstrated that intrabronchial inoculation of CPXV-Brighton Red (CPXV-BR) into cynomolgus monkeys resulted in a disease that shared many similarities to smallpox; however, severe respiratory tract disease was observed (Smith et al., 2011, J. Gen. Virol.). Here we describe the course of disease after small particle aerosol exposure of rhesus monkeys using computed tomography (CT) to monitor respiratory disease progression. Subjects developed a severe respiratory disease that was uniformly lethal at 5.7 log10 PFU of CPXV-BR. CT indicated changes in lung architecture that correlated with changes in peripheral blood monocytes and peripheral oxygen saturation. While the small particle aerosol inoculation route does not accurately mimic human smallpox, the data suggest that CT can be used as a tool to monitor real-time disease progression for evaluation of animal models for human diseases. Published by Elsevier Inc.

Entities:  

Keywords:  Aerosol inoculation; Animal model; CT; Computed tomography; Cowpox; Orthopoxvirus; Pathogenesis

Mesh:

Substances:

Year:  2015        PMID: 25776759      PMCID: PMC4535421          DOI: 10.1016/j.virol.2015.02.044

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  42 in total

Review 1.  Exotic emerging viral diseases: progress and challenges.

Authors:  Thomas W Geisbert; Peter B Jahrling
Journal:  Nat Med       Date:  2004-12       Impact factor: 53.440

2.  Comparative analysis of monkeypox virus infection of cynomolgus macaques by the intravenous or intrabronchial inoculation route.

Authors:  Reed F Johnson; Julie Dyall; Dan R Ragland; Louis Huzella; Russell Byrum; Catherine Jett; Marisa St Claire; Alvin L Smith; Jason Paragas; Joseph E Blaney; Peter B Jahrling
Journal:  J Virol       Date:  2010-12-08       Impact factor: 5.103

3.  Smallpox vaccine does not protect macaques with AIDS from a lethal monkeypox virus challenge.

Authors:  Yvette Edghill-Smith; Mike Bray; Chris A Whitehouse; David Miller; Eric Mucker; Jody Manischewitz; Lisa R King; Marjorie Robert-Guroff; Anna Hryniewicz; David Venzon; Clement Meseda; Jerry Weir; Aysegul Nalca; Virginia Livingston; Jay Wells; Mark G Lewis; John Huggins; Susan H Zwiers; Hana Golding; Genoveffa Franchini
Journal:  J Infect Dis       Date:  2005-01-04       Impact factor: 5.226

4.  Human monkeypox: secondary attack rates.

Authors:  Z Jezek; B Grab; M V Szczeniowski; K M Paluku; M Mutombo
Journal:  Bull World Health Organ       Date:  1988       Impact factor: 9.408

5.  Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo.

Authors:  Anne W Rimoin; Prime M Mulembakani; Sara C Johnston; James O Lloyd Smith; Neville K Kisalu; Timothee L Kinkela; Seth Blumberg; Henri A Thomassen; Brian L Pike; Joseph N Fair; Nathan D Wolfe; Robert L Shongo; Barney S Graham; Pierre Formenty; Emile Okitolonda; Lisa E Hensley; Hermann Meyer; Linda L Wright; Jean-Jacques Muyembe
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-30       Impact factor: 11.205

6.  Human monkeypox.

Authors:  Z Jezek; A I Gromyko; M V Szczeniowski
Journal:  J Hyg Epidemiol Microbiol Immunol       Date:  1983

7.  Real-time PCR assay to detect smallpox virus.

Authors:  M Sofi Ibrahim; David A Kulesh; Sharron S Saleh; Inger K Damon; Joseph J Esposito; Alan L Schmaljohn; Peter B Jahrling
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

8.  Cowpox virus infection of cynomolgus macaques as a model of hemorrhagic smallpox.

Authors:  Reed F Johnson; Srikanth Yellayi; Jennifer A Cann; Anthony Johnson; Alvin L Smith; Jason Paragas; Peter B Jahrling; Joseph E Blaney
Journal:  Virology       Date:  2011-08-15       Impact factor: 3.513

9.  Are we there yet? The smallpox research agenda using variola virus.

Authors:  Inger K Damon; Clarissa R Damaso; Grant McFadden
Journal:  PLoS Pathog       Date:  2014-05-01       Impact factor: 6.823

10.  ST-246 antiviral efficacy in a nonhuman primate monkeypox model: determination of the minimal effective dose and human dose justification.

Authors:  Robert Jordan; Arthur Goff; Annie Frimm; Michael L Corrado; Lisa E Hensley; Chelsea M Byrd; Eric Mucker; Josh Shamblin; Tove' C Bolken; Carly Wlazlowski; Wendy Johnson; Jennifer Chapman; Nancy Twenhafel; Shanthakumar Tyavanagimatt; Adams Amantana; Jarasvech Chinsangaram; Dennis E Hruby; John Huggins
Journal:  Antimicrob Agents Chemother       Date:  2009-02-17       Impact factor: 5.938

View more
  5 in total

1.  Exposure of rhesus monkeys to cowpox virus Brighton Red by large-particle aerosol droplets results in an upper respiratory tract disease.

Authors:  Reed F Johnson; Dima A Hammoud; Donna L Perry; Jeffrey Solomon; Ian N Moore; Matthew G Lackemeyer; Jordan K Bohannon; Philip J Sayre; Mahnaz Minai; Amy B Papaneri; Katie R Hagen; Krisztina B Janosko; Catherine Jett; Kurt Cooper; Joseph E Blaney; Peter B Jahrling
Journal:  J Gen Virol       Date:  2016-05-09       Impact factor: 3.891

2.  Influenza A and methicillin-resistant Staphylococcus aureus co-infection in rhesus macaques - A model of severe pneumonia.

Authors:  Daniel S Chertow; Jason Kindrachuk; Zong-Mei Sheng; Lindsey M Pujanauski; Kurt Cooper; Daniel Nogee; Marisa St Claire; Jeffrey Solomon; Donna Perry; Philip Sayre; Krisztina B Janosko; Matthew G Lackemeyer; Jordan K Bohannon; John C Kash; Peter B Jahrling; Jeffery K Taubenberger
Journal:  Antiviral Res       Date:  2016-02-26       Impact factor: 5.970

Review 3.  Challenges and Achievements in Prevention and Treatment of Smallpox.

Authors:  Sharon Melamed; Tomer Israely; Nir Paran
Journal:  Vaccines (Basel)       Date:  2018-01-29

4.  A spike-modified Middle East respiratory syndrome coronavirus (MERS-CoV) infectious clone elicits mild respiratory disease in infected rhesus macaques.

Authors:  Adam S Cockrell; Joshua C Johnson; Ian N Moore; David X Liu; Kevin W Bock; Madeline G Douglas; Rachel L Graham; Jeffrey Solomon; Lisa Torzewski; Christopher Bartos; Randy Hart; Ralph S Baric; Reed F Johnson
Journal:  Sci Rep       Date:  2018-07-16       Impact factor: 4.379

5.  Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate.

Authors:  Thomas Luke; Richard S Bennett; Dawn M Gerhardt; Tracey Burdette; Elena Postnikova; Steven Mazur; Anna N Honko; Nicholas Oberlander; Russell Byrum; Dan Ragland; Marisa St Claire; Krisztina B Janosko; Gale Smith; Gregory Glenn; Jay Hooper; John Dye; Subhamoy Pal; Kimberly A Bishop-Lilly; Theron Hamilton; Kenneth Frey; Laura Bollinger; Jiro Wada; Hua Wu; Jin-An Jiao; Gene G Olinger; Bronwyn Gunn; Galit Alter; Surender Khurana; Lisa E Hensley; Eddie Sullivan; Peter B Jahrling
Journal:  J Infect Dis       Date:  2018-11-22       Impact factor: 5.226

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.